DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20181547

Comparison of sedation scores after nebulized and intravenous Midazolam in children

Mounika M., Aswathy R., Shriyan A., Roshan A. O.

Abstract


Background: An efficacious, reliable, and non-invasive route of administration for midazolam, a drug used for sedation and pre-anesthetic medication, would have obvious advantages. This study compares the sedation achieved by nebulized route and intravenous route as procedural sedation.

Methods: A randomized double-blinded interventional study was designed to compare the effect of nebulized midazolam with intravenous midazolam as a sedative medication in 86 children undergoing imaging procedures like CT scan, MRI scan, EEG. Ramsay sedation scores and parameters of cardiovascular and respiratory function were measured over 20 min and summarized

Results: The mean sedation score in both groups was comparable at baseline, 10 minutes and 20 minutes with p values of 0.1, 0.1, 0.09 respectively. Parameters of cardiovascular and respiratory function were comparable in both the groups.

Conclusion: Present study showed that nebulized midazolam when given at a higher dose of 1 mg/kg was found to be as potent as intravenous midazolam, opening up a door for a sedative which is easier to administer, has better acceptance with lesser complication.


Keywords


Intravenous, Midazolam, Nebulised, Sedative

Full Text:

PDF

References


Gozal D, Mason KP. Pediatric sedation: a global challenge. Int J Pediatr. 2010;2010.

Mason KP. Challenges in paediatric procedural sedation: political, economic, and clinical aspects. Br J Anaesthesia. 2014;113:ii48-62.

McCormick AS, Thomas VL, Berry D, Thomas PW. Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers. Br J Anaesthesia. 2008;100(5):631-6.

Mahajan C, Dash HH. Procedural sedation and analgesia in pediatric patients. J Pediatr Neurosci. 2014;9(1):1.

Davies FC, Waters M. Oral midazolam for conscious sedation of children during minor procedures. Emerg Med J. 1998;15(4):244-8.

Pacifici GM. Clinical pharmacology of midazolam in neonates and children: effect of disease-a review. Int J Pediatr. 2014;2014.

Kaabachi O, Ouezini R, Hajjej Z, Rais K, Koubaa W. Comparative study between mask nebulisation and oral administration of midazolam for premedication in children: 10AP3-4. Eu J Anaesthesiol. 2008;25:158.

Rey E, Delaunay L, Pons G. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol. 1991;41:355-7.

Knoester PD, Jonker DM, van der Hoeven RTM. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol. 2002;53:501-7.

Payne K, Mattheyse FJ, Liebenberg D, Dawes T. The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol. 1989;37:267-72.

Khodadad A, Aflatoonian M, Jalilian R, Babaei N, Motamed F, Soltani AE, et al. Comparison of oral Midazolam with intravenous Midazolam for sedation children during upper gastrointestinal endoscopy. Acta Medica Iranica. 2016;54(9):576-82.